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ABSTRACT
RNA structure is a primary determinant of its func-
tion, and methods that merge chemical probing with
next generation sequencing have created break-
throughs in the throughput and scale of RNA struc-
ture characterization. However, little work has been
done to examine the effects of library preparation
and sequencing on the measured chemical probe
reactivities that encode RNA structural information.
Here, we present the first analysis and optimization of
these effects for selective 2′-hydroxyl acylation ana-
lyzed by primer extension sequencing (SHAPE-Seq).
We first optimize SHAPE-Seq, and show that it pro-
vides highly reproducible reactivity data over a wide
range of RNA structural contexts with no apparent bi-
ases. As part of this optimization, we present SHAPE-
Seq v2.0, a ‘universal’ method that can obtain reactiv-
ity information for every nucleotide of an RNA without
having to use or introduce a specific reverse tran-
scriptase priming site within the RNA. We show that
SHAPE-Seq v2.0 is highly reproducible, with reactiv-
ity data that can be used as constraints in RNA fold-
ing algorithms to predict structures on par with those
generated using data from other SHAPE methods.
We anticipate SHAPE-Seq v2.0 to be broadly appli-
cable to understanding the RNA sequence–structure
relationship at the heart of some of life’s most funda-
mental processes.
INTRODUCTION
RNAs play diverse functional roles in many natural cel-
lular processes (1), and are being increasingly engineered
to control these processes in many synthetic biology and
biotechnology applications (2). This diverse function of
RNA is intimately connected to its ability to fold into intri-
cate structures. Recently, high-throughput techniques that
combine nuclease digestion (3–5) or chemical probing (6–9)
with next-generation sequencing have started to shed new
light on the sequence/structure relationship of RNA. Be-
cause of the inherent multiplexing and enormous through-
put offered by sequencing-based approaches, these tech-
niques are providing some of the first ‘genome-wide’ snap-
shots of RNA structure (9,10)––effectively bringing RNA
structural biology into the ‘omics’ era (11).
Of these techniques, those that favor chemical probing
over nuclease digests show the most promise because of the
inherent versatility (12), higher resolution and in vivo acces-
sibility (9–10,13–15) of many chemical probes. Several such
techniques have been developed (selective 2′-hydroxyl acy-
lation analyzed by primer extension sequencing (SHAPE-
Seq) (6,7), DMS-Seq (9–10,13), MAP-Seq (8)) that each fol-
low the same general protocol consisting of: (i) structure-
dependent modification of the RNA in vitro or in vivo; (ii) re-
verse transcription (RT) of the modified RNA into a cDNA
pool whose length distribution reflects the location of mod-
ifications; (iii) sequencing library construction, involving
the addition of platform-specific adapter sequences to the
cDNA pool, optional amplification with polymerase chain
reaction (PCR) and quality control assessment steps; (iv)
sequencing of the library and (v) bioinformatic processing
of sequencing reads and calculation of reactivity spectra for
each RNA (Figure 1). While proving to be powerful, these
sequencing-based techniques are complex and involve many
more steps, including ligation and PCR, than approaches
that use electrophoretic analysis (Supplementary Figure S1)
(16–18). Very little work has been done to evaluate the im-
pact of these extra steps.
In this work, we systematically analyze and optimize
SHAPE-Seq, and present a new version, SHAPE-Seq v2.0,
that can obtain reactivity information for every nucleotide
of an RNA without requiring an internal RT priming site.
We start by analyzing SHAPE-Seq in the context of a panel
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Figure 1. The basic SHAPE-Seq protocol. In SHAPE-Seq (6,7), RNAs
are modified with chemical probes, such as 1M7 (24), or any probe that
covalently modifies the RNA in a structure-dependent fashion (12). RT of
the RNAs creates a pool of cDNAs, whose length distribution reflects the
distribution of modification positions. Control reactions are performed to
account for RT fall-off at unmodified positions. RT primer tails contain
a portion of one of the required Illumina sequencing adapters, while the
other is added to the 3′ end of each cDNA through a single-stranded DNA
ligation. A limited number of PCR cycles are used to both amplify the
library and add the rest of the required adapters prior to sequencing. A
freely available bioinformatic pipeline Spats (7,26–27) is then used to align
sequencing reads, correct for biases due to RT-based signal decay (26,27)
and calculate reactivity spectra for each RNA. See Supplementary Figures
S2–S4 for protocol details.
of RNAs used in previous benchmarking of chemical prob-
ing techniques (19–21). Specifically, we systematically in-
vestigate steps of the SHAPE-Seq protocol that differ from
more traditional methods that could affect measured reac-
tivity data, including sequence context effects of adapter lig-
ation, adapter ligation conditions, RT primer modifications
and PCR. During this process, we optimize several of these
steps, and show that they do not appear to be a source of
differences between SHAPE-Seq and electrophoresis-based
SHAPE analysis. We also show that SHAPE-Seq is highly
reproducible, and report replicate reactivity spectra for each
RNA in the panel.
Finally, we present SHAPE-Seq v2.0 and show that it re-
capitulates SHAPE-Seq reactivity spectra, but without re-
quiring a specific RT priming site to be present on the target
RNAs. SHAPE-Seq v2.0 significantly expands the capabil-
ity of SHAPE-Seq by allowing it to be performed through
a ‘kit’-like protocol independent of the RNAs studied. We
also show that SHAPE-Seq v2.0 reactivity data can be read-
ily incorporated into RNA structure prediction algorithms
to give experimentally constrained predicted folds that are




For SHAPE-Seq v1.0, RNAs were generated through in
vitro transcription reactions with T7 RNA polymerase.
DNA templates consisted of a preceding 17-nucleotide T7
promoter, an optional 14-nucleotide 5′ structure cassette
sequence (22), the desired RNA coding sequence and an
optional 43-nucleotide 3′ structure cassette sequence (7,22)
(Supplementary Table S1). DNA templates were generated
by PCR [1 ml; containing 20 mM Tris (pH 8.4), 50 mM KCl,
2.5 mM MgCl2, 200 M each dNTP, 500 nM each forward
and reverse primer, 5 pM template and 0.025 U/l Taq
polymerase; denaturation at 94◦C, 45 s; annealing 55◦C, 30
s and elongation 72◦C, 1 min; 34 cycles]. The PCR prod-
uct was recovered by ethanol precipitation and resuspended
in 150 l of TE [10 mM Tris (pH 8.0), 1 mM ethylene-
diaminetetraacetic acid (EDTA)]. Transcription reactions
(1.0 ml, 37◦C, 12–14 h) contained 40 mM Tris (pH 8.0),
20 mM MgCl2, 10 mM DTT, 2 mM spermidine, 0.01%
(vol/vol) Triton X-100, 5 mM each NTP, 50 l of PCR-
generated template, 0.04 U/l SuperaseIN RNase Inhibitor
(Ambion) and 0.1 mg/ml of T7 RNA polymerase. The
RNA products were purified by denaturing polyacrylamide
gel electrophoresis (8% polyacrylamide, 7 M urea, 35 W, 3
h), excised from the gel using an appropriately placed sacri-
fice lane for ultraviolet shadowing and recovered by passive
elution and ethanol precipitation. The purified RNA was
resuspended in 50 l TE, and concentrations were measured
with the Qubit fluorimeter. All of the RNAs with the flank-
ing structure cassettes contained a unique four-nucleotide
bar code to multiplex SHAPE-Seq v1.0 experiments as de-
scribed previously (7) (Supplementary Table S1). In gen-
eral, QuSHAPE and SHAPE-Seq v1.0 experiments were
performed on RNAs containing the optional structure cas-
settes, while SHAPE-Seq v2.0 experiments were performed
on RNAs without these cassettes (Supplementary Table
S1).
For SHAPE-Seq v2.0 RNAs, each RNA sequence was al-
tered to begin with GG, and cloned between the T7 RNA
promoter and Hepatitis  (HepD) antigenomic ribozyme
and PCR amplified. The resulting templates were tran-
scribed in vitro using T7 RNA polymerase as above, and
purified by standard gel excision methods (23). For the
HepC IRES and cyclic-di-GMP Riboswitch, standard run-
off transcription was performed without the ribozyme to
obtain higher yields. A table of all RNA sequences used in
this study can be found in Supplementary Table S1.
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RNA modification
For the initial benchmarking and optimization studies,
all RNAs were folded and modified individually with 1-
methyl-7-nitroisatoic anhydride (1M7) (6.5 mM, final) in
batches (24). The RNAs (50 pmol in 60 l) were denatured
by heating at 95◦C for 2 min, and snap-cooled on ice for 60
s before the addition of 30 l of folding buffer. The sample
was refolded in the 1× folding buffer (10 mM MgCl2, 100
mM NaCl and 100 mM HEPES (pH 8.0)), in a total volume
of 90 l for 20 min at 37◦C. These reaction volumes were
split and added to 5 l 1M7 (10×, 65 mM in dry dimethyl
sulfoxide (DMSO)) and 5 l dry DMSO to form the (+) and
(–) reactions, respectively. Reactions were complete after 70
s at 37◦C. RNAs were recovered by the addition of 50 l of
water, 10 l of 3M NaOAc, 1 l of 20 mg/ml glycogen and
300 l of 100% ethanol, followed by incubation at –80◦C
for 30 min and centrifugation (15k rpm) at 4◦C for 30 min.
Multiple batches of the same RNAs were combined into an
overall stock of 700 pmol RNA (350 pmol unmodified (+),
350 pmol modified (–), each in 70 l TE), and stored at –
20◦C until use (<3 weeks).
For v1.0 replicate experiments, RNAs were folded as de-
scribed above. For v2.0, RNAs were folded in 20 pmol
batches in 12 l, with the addition of the folding buffer
bringing the total volume to 18 l. In addition, only 1 l
1M7 and 1 l dry DMSO were used for the (+) and (–) re-
actions and recovery required the addition of 90 l H2O in-
stead of 40 l. Buffer conditions and ligand concentrations
for each RNA are listed in Supplementary Table S2.
QuSHAPE
For QuSHAPE experiments, 10 pmol from the modified
(+) and unmodified (–) batches of RNA were suspended in
10 l of water. Two sequencing lanes were also established
with 10 pmol of purified RNA in 9 l of water. RT reac-
tion mixtures were prepared with the addition of 3 l of 0.3
M Vic-labeled [(+) and one of the sequencing lanes, usu-
ally ddT] or Ned-labeled [(–) and the other sequencing lane,
usually ddA] RT primer, with sequence GAACCGGACC-
GAAGCCCG. Primers were annealed following denatura-
tion at 95◦C for 2 min and 65◦C for 5 min and immediate
snap-cooling. Primer extension reactions were preformed
by the addition of 1 l of Superscript III, 4 l of 5× Super-
script First Strand Buffer, 0.4 l of dNTPs at 10 mM each
(dATP, dCTP, dTTP, dITP), 1 l of 0.1 M DTT and 0.6 l
of water. Following previous capillary electrophoresis meth-
ods, dITP was used instead of dGTP to reduce band com-
pression and increase resolution of primer extension prod-
ucts by capiliary electrophoresis (25). Note that 1 l of 10
mM pertinent di-deoxy stocks (usually ddATP or ddTTP)
was added to the appropriate sequencing lanes as well. The
reaction mixtures (total volume of 20 l) were incubated at
45◦C for 1 min, 52◦C for 25 min and 65◦C for 5 min. Then
4 l of 50 mM EDTA (pH 8.0) was added to each sam-
ple, and oppositely labeled primers (i.e. modified and ddA;
unmodified and ddT) combined, precipitated with ethanol,
resuspended in 10 l of Hi-Di formamide and resolved on
an Applied Biosystems 3730xl capillary electrophoresis in-
strument. Raw capillary electrophoresis traces were pro-
cessed using QuSHAPE software as described in Karabiber
et al. (18). QuSHAPE reactivities were then converted to
QuSHAPE θ ’s by dividing by a normalization factor so that
they summed to 1 over the range of nucleotides for which
reactivity data was obtained.
SHAPE-Seq RT
RT conditions differed based on the particular library con-
struction strategy. The details of RT primers and adapter
configurations for SHAPE-Seq library preparation strate-
gies can be found in Supplementary Figures S2–S4. For
SHAPE-Seq v1.0 (Supplementary Figures S2 and S3), the
general procedure for RT was carried out following the
primer extension protocol in Mortimer et al. (7). The total
amount of primer used in primer extension reactions was
9 pmol (3 l of 3 M primer), with the RNA concentra-
tion being 50 pmol in 10 l. Primers were annealed by in-
cubation at 95◦C for 2 min and at 65◦C for 5 min. Primer
extension reactions were performed by the addition of 200
U of Superscript III, 4 l of 5× Superscript First Strand
Buffer, 0.4 l of dNTPs at 10 mM each (dATP, dCTP, dTTP,
dGTP), 1 l of 0.1 M DTT and 0.6 l of water. The reaction
mixtures (total volume of 20 l) were incubated at 45◦C for
1 min, 52◦C for 25 min and 65◦C for 5 min. After primer
extension, RNA was hydrolyzed by adding NaOH (1 l, 4
M) and incubating for 5 min at 95◦C. cDNAs were ethanol
precipitated and resuspended in 71 l of nuclease-free wa-
ter.
For SHAPE-Seq v2.0 (Supplementary Figure S4), RNAs
were not purified after the modification step. Instead, a
linker sequence was added to the 3′ end of the RNA tem-
plate via 5′-App Ligation by adding 6.5 l 50% PEG 8000,
2 l 10× T4 RNA Ligase Buffer (NEB), 1 M 5′ App IDT
miRNA linker 2 (5′App-CACTCGGGCACCAAGGAC-
3′ddC) and 0.5 l T4 RNA Ligase, truncated KQ (NEB)
directly to the modified RNA. Samples were incubated
overnight at room temperature, recovered by ethanol pre-
cipitation and resuspended in 10 l of nuclease-free wa-
ter. RT was then carried out as above using 1.5 pmol RT
primer (3 l at 0.5 M) complementary to the linker se-
quence, and containing flanking Illumina adapter sequence
and custom internal barcodes to create unique 3′ end align-
ments and increase randomness during Illumina sequencing
(Supplementary Figure S4 and Table S3). Hydrolysis was
performed the same way, but partially quenched with 1.5
l of 1 M HCl. After EtOH precipitation, the cDNAs were
dissolved in 22.5 l nuclease-free water.
SHAPE-Seq second adapter ligation
Adapter ligations differed based on the particular library
construction strategy (Supplementary Figures S2–S4). In
all SHAPE-Seq v1.0 cases, adapter sequences were ligated
to each cDNA using a ssDNA ligase (CircLigase, Epicentre
Biotechnologies) [100 l; 50 mM MOPS (pH 7.5), 10 mM
KCl, 5 mM MgCl2, 1 mM DTT, 0.05 mM ATP, 2.5 mM
MnCl2, 5 M adapter and 200 U ligase] and incubating for
6 h at 68◦C in a thermal cycler. For SHAPE-Seq v2.0, the
ligation was performed in 30 l by mixing 50 mM MOPS
(pH 7.5), 10 mM KCl, 5 mM MgCl2, 1 mM DTT, 0.05 mM
ATP, 2.5 mM MnCl2, 1.67 M adapter (Supplementary
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Figure S4) and 100 U ligase, incubated at 60◦C for 2 h. Sep-
arate ligation reactions were carried out for the (+) and (−)
cDNA library pools. The ligation reactions were stopped
by heating to 80◦C for 10 min, recovered by ethanol pre-
cipitation and resuspended in 20 l of nuclease-free water.
Excess adapter was removed using Agencourt Ampure XP
beads following the manufacturer’s protocol, eluting with
20 l TE.
SHAPE-Seq PCR, library QC and sequencing
Ligated libraries were then used as inputs into PCR reac-
tions using 6, 9, 12 or 20 cycles of PCR amplification as
indicated in Results. PCR primers contained sequences re-
quired for Illumina sequencing and index multiplexing as
indicated in Supplementary Figures S2–S4. A 50 l PCR
reaction contained 2.5 l of cDNA template, 1 l of 100
M forward and reverse primers, 1 l of 10 mM dNTPs, 10
l 5× Phusion Buffer, 33.5 l water and 1 U Phusion DNA
polymerase (NEB). Multiple reactions were made together
and split before the pertinent number of PCR amplification
cycles. PCR reactions were cleaned up with Agencourt Am-
pure XP beads following the manufacturer’s protocol, elut-
ing with 20 l TE. No direct size selection was performed on
the resulting adapter-ligated library. Libraries were assayed
for quality in one of two methods: (i) using an Agilent Bio-
analyzer 2100 high-sensitivity DNA chip to compare 9- and
12-cycle amplification, looking for characteristic peaks and
peak enrichment as described in Mortimer et al. (7) or (ii)
using fluorescently labeled PCR primers to generate frag-
ments to be analyzed by capillary electrophoresis, looking
for the same features.
The 9-cycle PCR amplification products (unless other-
wise indicated in Results) were then sequenced on an Il-
lumina MiSeq or HiSeq platform following the manufac-
turer’s standard cluster generation and sequencing proto-
cols. For runs that consisted of multiple RNAs, (+) and (–)
channels were balanced for molarity, and loaded to reach a
final concentration of at least 2 ng/l. This was then diluted
according to the standard Illumina sequencing protocols.
SHAPE-Seq data analysis
Fastq files generated from the Illumina sequencing pro-
cess were analyzed using the freely available software pack-
age Spats (spats.sourceforge.net), as described in (7,26–27).
Spats takes paired-end fastq files and performs bioinformat-
ics read alignment and a maximum-likelihood-based sig-
nal decay correction (6–7,26–27) to calculate SHAPE-Seq
θ values for each nucleotide of an RNA. In SHAPE-Seq
experiments, reactivity data are presented as  = {θi ; i =
1..L}, which is a probability distribution over the length of
an RNA, L, representing the probability, θ i, that each nu-
cleotide, i, is modified by the modification reagent (26,27).
SHAPE-Seq θ ’s are similar to more traditional SHAPE re-
activity data (typically referred to as a set of reactivity num-
bers for each nucleotide, {ri }), except that θ ’s are constrained
to sum to 1 over the length of the RNA since they represent
a probability distribution, i.e.
∑L
i=1 θi = 1. Thus, θ ’s are in-
dependent of scale factors typically used to define SHAPE
reactivities (19,21,28–29), and can be rigorously calculated
from the observed (+) and (–) fragment distributions in a
SHAPE-Seq experiment (7,26–27).
For this work, we used Spats v0.8.0, which contains an
updated adapter trimming algorithm. Once installed, a typ-
ical spats command was executed by entering:
python adapter trimmer.py --A-b-sequence
<second adapter sequence> --A-t-sequence
<first adapter sequence> --read-len 35
R1.fastq R2.fastq RNA targets.fa
spats --num-mismatches 0 -o Output
RNA targets.fa RRRY YYYR combined R1.fastq
combined R2.fastq
where <second adapter sequence> is the sequence of
the second adapter, <first adapter sequence> is the se-
quence of the first adapter, R1.fastq and R2.fastq are the
fastq sequencing files and RNA targets.fa is the FASTA
formatted file containing the RNA sequences under study.
Spats outputs text files containing (+) and (–) fragment
counts and θ ’s, for each position in each RNA in the tar-
gets file. Fragment distributions were calculated by dividing
the fragment counts at each position by the total number
of fragments observed in the channel, so that the fragment
distribution summed to 1 over the length of the RNA.
Computational modeling
The Fold executable of the RNAStructure (30) software
package (version 5.5) was used to calculate SHAPE-Seq-
constrained RNA secondary structures. For each RNA,
SHAPE-Seq v2.0 θ ’s were first converted into ρ values by
multiplying by the length of the RNA, L (Equation (1)).
Due to the inability to uniquely align reads containing a sin-
gle nucleotide, L was one nucleotide less than the full length
of the RNA used in experiments. The flags ‘-sh’, ‘-sm’ and
‘-si’ were used to input the SHAPE-Seq ρ data file, slope
m and intercept b, respectively. The parameters m and b
were used to define the pseudo-free energy Gi = m ln(ρi +
1) + b that was used in the minimum free energy (MFE)
structure calculation (20,28–30). The sensitivity and posi-
tive predictive value (PPV) of each predicted RNA struc-
ture was evaluated using the RNAStructure (30) Scorer ex-
ecutable (version 5.5), using the established crystallographic
secondary structure as the accepted structure (19–21). The
entire RNA sequence was used in these calculations except
for nucleotides at the very 5′ end of the RNAs that were in-
cluded for RNA synthesis using T7 polymerase. A table of
RNA sequences used can be found in Supplementary Table
S1.
RESULTS
Investigation and optimization of SHAPE-Seq library prepa-
ration
There are two distinct protocol steps associated with se-
quencing library preparation that distinguish SHAPE-Seq
from SHAPE analyzed by capillary electrophoresis (Figure
1, Supplementary Figure S1): adapter ligation and PCR.
Here, we sought to investigate if these steps impact the mea-
sured fragment distributions and reactivities for a set of
RNAs that have been used in other recent SHAPE bench-
marking experiments (6–7,19–21). The starting panel, cho-
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Figure 2. A comparison of SHAPE-Seq v1.0 to adapter ligation variations. SHAPE-Seq libraries on the same pools of modified and unmodified RNAs were
constructed and sequenced using the standard adapter configuration (v1.0), a shortened second adapter (Minimal) or an adapter layout where sequences
were switched between RT primer tail and second ligation (Inverted) (Supplementary Figure S2). For each RNA and each configuration, the (+) and
(–) fragment distributions (per nucleotide frequencies) are compared. Circles represent the v1.0 versus Minimal comparison and triangles represent the
v1.0 versus Inverted comparison. Filled/open symbols are for (+)/(–) fragment distributions, respectively, and are color coded according to the RNA as
indicated in the table, which contains Pearson’s correlation (R) values for the comparisons.
sen for the abundance of crystallographic and SHAPE
structural data available in the literature, consisted of the
RNAse P specificity domain from Bacillus subtilis, unmodi-
fied tRNAphe from Escherichia coli, the P4-P6 domain of the
Tetrahymena group I intron ribozyme, the 5S rRNA from
E. coli and the aptamer domain from the Vibrio vulnificus
adenine riboswitch (Supplementary Table S1).
Adapter ligation. One of the most distinct differences be-
tween SHAPE-Seq and capillary electrophoresis methods
like QuSHAPE (18) is the ligation of a second adapter se-
quence required for Illumina sequencing (Figure 1, Supple-
mentary Figure S1). The previously published SHAPE-Seq
protocol (SHAPE-Seq v1.0) uses single-stranded DNA (ss-
DNA) ligation to add a 61 nt ssDNA oligonucleotide to the
3′ end of the cDNA required for sequencing. This oligo con-
sists of the Illumina RD2 and P7 sequences used for priming
sequencing and flow cell binding, respectively (Supplemen-
tary Figure S2) (7). It was hypothesized that this ligation
step could introduce bias in SHAPE-Seq measurements due
to sequence or structure-specific ligation efficiencies.
We began by comparing SHAPE-Seq v1.0 reactivity spec-
tra to QuSHAPE reactivities for each panel RNA, using
the same starting pools of modified (+) and unmodified (–)
RNAs. Overall there was a strong degree of correlation be-
tween the two methods for each of the RNAs and we did
not find any systematic differences in reactivity spectra that
would suggest ligation was causing biases (Supplementary
Figure S5).
We therefore tested two other adapter variants: a trun-
cated ‘Minimal’ adapter (25 nt) (Supplementary Figure
S2b) and an ‘Inverted’ layout where the RT primer tail and
the adapter sequences were switched (Supplementary Fig-
ure S2c). These libraries tested whether the adapter length
(Minimal), or sequence (Inverted) would contribute to po-
tential ligation bias, while staying within the sequence con-
straints of the Illumina platform. After constructing and
sequencing these libraries from the same modified and un-
modified RNA pools, we compared cDNA fragment length
distributions, since changes in ligation conditions only af-
fect the sampling of the modified or unmodified RNA frag-
ments (Figure 2). The aggregate Pearson’s correlation coef-
ficients (R) across all RNAs in the panel show that these
distributions are in good agreement, with R values rang-
ing from 0.89 to 0.93. Comparisons between adapter vari-
ants for individual RNAs also showed a strong correlation,
with values ranging from 0.82 to 0.99, except for two spe-
cific cases: RNase P v1.0 versus Minimal (–) (R = 0.66) and
tRNA v1.0 versus Inverted (+) (R = 0.63) (Figure 2). These
discrepancies for the RNAse P case mostly arose from dif-
ferences between the ends of the (–) distribution, though
these differences do not cause major discrepancies in the
overall {θ i} calculation (R = 0.92) (Supplementary Figure
S6a). Like RNAse P, the tRNA distributions only show ma-
jor differences at the 5′ and 3′ ends, but these differences do
cause a discrepancy in the {θ i} calculation (R = 0.68) (Sup-
plementary Figure S6b).
While constructing these libraries, we also investigated
the ligation conditions in general, including enzyme choice,
ligation temperature and specific blocking groups used to
prevent adapter concatenation during ligation. Previous
work by Kwok et al. demonstrated that there was much
room for improvement in the ssDNA ligation step, and de-
vised an alternate T4 DNA ligase-based method (31). How-
ever, our concern that secondary structures could poten-
tially cause uncharacterized ligation bias at the low tem-
peratures required for T4 DNA ligase (31) led us to instead
improve the CircLigase reaction originally used in SHAPE-
Seq v1.0 (7). We began by performing a time course assay
on the SHAPE-Seq v1.0 ligation reaction. We ligated the
61 nt SHAPE-Seq v1.0 Illumina adapter (Supplementary
Figure S2) to a 126 nt cDNA for varying amounts of time
(Supplementary Figure S7) and found a saturation in lig-
ated product after 1–2 h. We next compared CircLigase II to
CircLigase I for potential improved ligation efficiency (Sup-
plementary Figure S8). A 2 h ligation of an RT primer to the
Illumina 61 nt adapter at 68◦C was compared to ligation at
60◦C for each ligase. Both ligases performed better at 60◦C,
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Figure 3. Characterization of varying numbers of PCR cycles in SHAPE-Seq library construction. SHAPE-Seq v1.0 libraries were constructed for tRNA
and 5S rRNA using either 6×, 9×, 12× or 20× cycles of PCR before sequencing. (+) and (–) fragment distributions for each RNA were compared between
6× cycles and the other cycle numbers as in Figure 2. Pearson’s correlation values (R) for individual comparisons between fragment distributions, and {θ i}
distributions, are shown on the bottom.
with Circligase I at 60◦C being the optimal condition tested
(Supplementary Figure S8).
We also investigated blocking groups on the 5′ end of the
RT primer, and 3′ end of the Illumina adapter (Supplemen-
tary Figure S2) for their importance in preventing concate-
mer formation during ligation (Supplementary Figures S9
and S10). First, an unblocked or biotin-blocked RT primer
was ligated to the 25 nt Minimal Illumina adapter (Sup-
plementary Figure S9). Though the unblocked and blocked
RT primers performed equivalently, we proceeded with the
biotin-blocked primer (Supplementary Figure S9). We next
tested 3′ di-deoxy-cytosine, phosphate and 3-carbon spacer
modifications to the Illumina second adapter designed to
prevent adapter concatemerization (Supplementary Figure
S10). We ligated the blocked adapter to an RT primer that
was either 5′ blocked with biotin or unblocked, using Cir-
cLigase I. All 3′ modifications showed some degree of con-
catemer formation, with the phosphate modification pro-
ducing the most concatemer (Supplementary Figure S10).
We recommend the 3-carbon spacer modification, as it dis-
played lower amounts of concatemer formation and is less
expensive than di-deoxy-cytosine.
PCR amplification. Another distinct difference between
SHAPE-Seq and SHAPE analyzed by capillary elec-
trophoresis is the use of PCR to build and amplify SHAPE-
Seq libraries before sequencing. PCR can be a powerful fea-
ture of SHAPE-Seq library construction, as it can amplify
low signals (32), add custom barcodes or library indexes
or complete adapter sequences as in the Minimal library
above (Supplementary Figure S2c). However, PCR could
introduce a systematic bias in the SHAPE-Seq measure-
ment since certain fragments can be preferentially ampli-
fied.
To test the effects of PCR on measured fragment distri-
butions, we created SHAPE-Seq v1.0 libraries for tRNA
and 5S rRNA using either 6, 9, 12 or 20 cycles of PCR
amplification before sequencing (Figure 3). A comparison
between the 6× and 9× (+) and (–) distributions for each
RNA showed near perfect agreement, with R values rang-
ing from 0.97 to 1.0 (Figure 3), indicating that the PCR cy-
cles used in SHAPE-Seq v1.0 (9×) are not biasing these dis-
tributions. The comparison between 6× and 12× was sim-
ilar, with the R values ranging from 0.86 to 1.0. Even the
comparison between 6× and 20× showed strong agreement,
with R values ranging from 0.83 to 0.98. For all of the worst
comparisons, with R values of 0.83 to 0.86, the discrepancy
stemmed mostly from a few positions rather than a system-
atic length bias across the lengths of the RNAs. Specifically,
the shortest fragments for the 5S 12× (–) and 20× (–) frag-
ment distributions differed slightly (Supplementary Figure
S11). For the tRNA (+) distribution, there were six po-
sitions that showed a similar discrepancy (Supplementary
Figure S11). Regardless of these discrepancies in the (+) and
(–) distributions, the comparisons between {θ i} values be-
tween the different PCR cycle conditions yielded R values
in the range of 0.97–1.0 (Figure 3), indicating that up to 20
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Figure 4. Schematic of traditional SHAPE/SHAPE-Seq v1.0 RT prim-
ing strategies and the universal RT priming strategy of SHAPE-Seq v2.0.
Traditional strategies use sequences that are part of the RNA, or added
structure cassette flanking sequences to prime RT reactions. In SHAPE-
Seq v2.0, a linker sequence is added to the RNA post-modification, which
serves as a priming site for the RT reaction (see Supplementary Figure S4).
PCR cycles can be used without the introduction of system-
atic bias in SHAPE-Seq reactivities.
Assessing the reproducibility of SHAPE-Seq
Replicate indexed SHAPE-Seq experiments were per-
formed using a similar configuration as the minimal adapter
library above, except that a 34 nt adapter sequence was
used instead to take advantage of Illumina TruSeq multi-
plexing (Supplementary Figure S3). Replicates, measured
from completely independent library preparations, were ob-
tained for the five panel RNAs discussed above, as well
as four additional RNAs––the cyclic di-GMP bacterial ri-
boswitch from V. cholerae, the TPP riboswitch from E. coli,
the SAM I riboswitch from T. tencongensis and the Hep-
atitis C virus IRES domain––all of which have been used
in previous SHAPE benchmarking experiments (19–21). As
indicated in Experimental Procedures, folding conditions
included ligands where appropriate (Supplementary Table
S2). The results showed that the SHAPE-Seq technique is
highly reproducible for all nine RNAs (Figure 5, Supple-
mentary Figure S12).
SHAPE-Seq v2.0: removing RNA sequence requirements
with universal RT priming
One major limitation to the SHAPE methods described
above is the requirement of priming the RT step either
within the RNA sequence itself, or by including structure
cassette sequences that contain a 3′ RT primer binding site
(Figure 4) (22). In the case of priming within the RNA it-
self, custom primers must be used for each RNA, and struc-
tural information is lost at the site of RT priming. In the
structure cassette case, flanking sequences must be added to
the RNA itself, with the potential to alter the folded struc-
tures of the RNAs. SHAPE-Seq v2.0 creates a ‘universal’
RT primer binding site by ligating a linker sequence to the
3′ end of the RNA after modification (Figure 4, Supplemen-
tary Figure S4).
3′ ligation methods and other protocol adjustments. We fo-
cused specifically on ligating pre-adenylated linkers using
truncated T4 RNA ligase 2 to prevent unwanted side reac-
tion products. We tested ligation conditions using three pre-
viously designed and tested miRNA cloning linkers (33,34)
available from Integrated DNA Technologies. As shown in
Supplementary Figure S13, each IDT linker was effective
at ligating to the tRNAphe sequence. We chose linker 2 for
having the highest melting temperature with respect to its
complementary RT primer.
The addition of the 3′ ligation step required a number
of protocol adjustments to improve cDNA yield and re-
duce side products. A critical adjustment was reducing the
amount of RT primer used (see Experimental Procedures).
This had the effect of reducing the amount of unextended
primer left over after RT, and thus reducing the amount
of unwanted side product, which increases the usable sig-
nal from the sequencing run. As described above in Exper-
imental Procedures, we also altered many other intermedi-
ate steps of SHAPE-Seq, culminating in SHAPE-Seq v2.0
(Supplementary Figure S4).
Comparison of SHAPE-Seq v2.0 and v1.0. Reactivity
spectra generated with SHAPE-Seq v2.0 and v1.0 are com-
pared in Figure 5. Pearson’s correlation coefficients were
between 0.80 and 0.95, supporting a strong correlation be-
tween v1.0 and v2.0 results. Of the RNAs with weaker cor-
relations (namely, cyclic-di-GMP Riboswitch (R = 0.83),
RNAse P (R = 0.80) and 5S rRNA (R = 0.85)), the main
qualitative differences tend to be at the ends of the RNA
molecule, with v2.0 tending toward higher θ values at the 5′
end, and v1.0 higher at the 3′ end (Figure 5, Supplementary
Figure S12).
Using SHAPE-Seq reactivities as constraints in thermody-
namic RNA folding algorithms
While our primary goal was to assess the ability of SHAPE-
Seq to generate accurate and reproducible reactivity data
in a high-throughput manner, it is important to recognize
downstream uses of this information. One common use is
to constrain thermodynamic RNA folding algorithms (19–
21,28–29,35). In this approach, each SHAPE reactivity, ri,
of an RNA is converted into a GSHAPE,i = mln(ri + 1) +
b, which are then used to predict RNA secondary structural
properties, such as the MFE structure. The parameters m
and b are fit to produce the most accurate structural predic-
tions over a benchmark set of RNAs for which reactivity
information is available (28). Secondary structure predic-
tion accuracy is assessed by comparing the predicted MFE
structure to the crystal structure using two representative
statistical measures: sensitivity, or the fraction of base pairs
in the accepted (crystal) structure predicted correctly; and
PPV, which is the fraction of predicted pairs that are cor-
rect (35). Overall, the incorporation of SHAPE reactivity
data into thermodynamic structure prediction algorithms
has been shown to increase the accuracy of predictions (19–
21,28–29).
To incorporate SHAPE-Seq reactivity data into folding
algorithms, we converted θ ’s to a scale that is more simi-
lar to the reactivity scale typically used for SHAPE experi-
ments. In traditional SHAPE data scaling, ‘highly reactive’
positions are set to a reactivity of ∼1 by scaling to a nor-
malization factor that averages the reactivities of these po-
sitions while excluding outliers (29). In SHAPE-Seq, θ ’s are
guaranteed to be <1 due to the constraint that they sum
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Figure 5. SHAPE-Seq v2.0 versus SHAPE-Seq v1.0. (a) Reactivity spectra θ ’s are plotted for each RNA, including error bars which are calculated as
standard deviations of reactivities at each nucleotide from three independent replicate experiments for SHAPE-Seq v2.0 (blue) and SHAPE-Seq v1.0 (red).
Pearson’s correlations from the comparisons of average reactivity spectra are shown in each plot and listed in the table in (b). Supplementary Figure S12
shows detailed comparisons for each RNA in the panel.
to 1 over the length of the RNA, thus SHAPE-Seq θ ’s are
smaller than typical reactivities. However, θ ’s can be easily
converted to a similar scale by multiplying θ ’s by the length
of the RNA, L. Defining
ρi = Lθi (1)










making ρ’s on roughly the same scale as SHAPE r’s. There-
fore, we used SHAPE-Seq v2.0 ρ’s to evaluate sensitivity
and PPV predictions for each RNA in the panel (Table 1).
As seen from Table 1, when we used the current recom-
mended values of m = 1.8 and b = −0.6, we observe an
increase in the total sensitivity and PPV values over un-
constrained folds. These values are in fact comparable to
results from recent studies that used QuSHAPE reactivity
with these parameters (20). However, since ρ’s are slightly
different than SHAPE r’s, we anticipated that there could
be room to adjust m and b values. We found that m = 1.1
and b = −0.3 gave total sensitivity and PPV values over the
panel to be 84% and 89%, respectively, with many RNAs in
the panel predicted to a very high sensitivity and PPV in-
dividually (Table 1, Supplementary Table S6). We empha-
size that m = 1.1 and b = –0.3 should serve as a guide for
incorporating SHAPE-Seq reactivity data into folding al-
gorithms, though more work should be performed to refine
these values over a broader context of RNA structures.
DISCUSSION
In this work, we present a systematic analysis and optimiza-
tion of the SHAPE-Seq technique to structurally character-
ize RNAs in a high-throughput, multiplexed fashion. Over-
all, the above results demonstrate that our optimizations to
the previously published SHAPE-Seq v1.0 technique (6,7)
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Table 1. RNA structure prediction accuracy using the RNAStructure (30) Fold algorithm and the SHAPE-Seq v2.0 reactivity data (ρ’s) as constraints,
with different m and b parameters
RNA Total sensitivity Total PPV
No SHAPE data 228/360 = 63.3% 229/373 = 61.4%
SHAPE parameters (m = 1.8 and b = −0.6) 292/360 = 81.1% 293/351 = 83.5%
SHAPE-Seq updated parameters (m = 1.1 and b = −0.3) 303/360 = 84.2% 304/342 = 88.9%
Sensitivity and PPV values for each RNA are in Supplementary Tables S4–S6.
provide highly reproducible nucleotide resolution chemical
reactivity data over the wide array of structural contexts
present in our panel of benchmark RNAs (Figure 5).
Initial comparisons between reactivities generated from
before SHAPE-Seq v1.0 optimization and QuSHAPE
showed there was a strong overall correlation between the
two methods, with specific differences highlighted by the in-
spection of individual reactivity spectra. As shown in Sup-
plementary Figure S5, for most of the RNAs, SHAPE-Seq
v1.0 and QuSHAPE capture the same clusters of reactive
nucleotides, but differ in the specific θ value assigned to
these positions. There does, however, appear to be a dif-
ference between the two techniques at low reactivity nu-
cleotides. In particular, there are a large number of nu-
cleotide positions (216 out of a total of 586) where the
SHAPE-Seq θ is 0, while the QuSHAPE θ is a small, non-
zero number. We hypothesize that the analog nature of
the capillary electrophoresis read-out in QuSHAPE exper-
iments, and the Gaussian fitting algorithm used to quan-
tify electopherogram peaks, can amplify baseline noise and
make zero reactivity peaks appear to have a small but non-
zero reactivity.
We systematically optimized each step of the SHAPE-
Seq v1.0 protocol associated with library preparation and
sequencing, which constitute the major differences be-
tween SHAPE-Seq and SHAPE analyzed by capillary elec-
trophoresis. As shown above, steps such as adapter ligation
(Figure 2) and PCR (Figure 3) do not appear to introduce
a systematic bias in SHAPE-Seq reactivity data.
We also sequenced three SHAPE-Seq v2.0 libraries on
both the HiSeq and MiSeq platforms. All three show a very
strong correlation between the HiSeq and MiSeq for the (+)
and (–) read distributions, with R values for these compar-
isons all in excess of 0.99 (Supplementary Figure S14). This
indicates that the choice of sequencing platform has no ef-
fect on SHAPE-Seq data.
We then expanded the flexibility of the SHAPE-Seq tech-
nique by incorporating the standard Illumina library index-
ing strategy to sequence multiple libraries in the same lane
(Supplementary Figures S3 and S4). This can be used in a
number of ways, for example, by using indexes to perform
replicate experiments on the same RNA, or to run different
groups of RNAs together as done in this work. In principle,
this flexibility allows any number of experimental variations
to be performed.
We have also significantly extended SHAPE-Seq by cre-
ating a universal RT priming strategy that does not require
RNA-specific primers to be designed and used, or flanking
sequence to be added to the RNA itself. This new technique,
SHAPE-Seq v2.0, works by ligating a linker sequence af-
ter modification, which can then serve as an RT priming
site. With this innovation, SHAPE-Seq v2.0 can now be
performed on unknown RNAs, without the need to deal
with the complexities and biases associated with random
RT primers (9,10). In addition, SHAPE-Seq v2.0 allows re-
activity information to be characterized for almost the en-
tire length of the RNA, without losing structural informa-
tion at RT priming sites within the RNA sequence. Finally,
SHAPE-Seq v2.0 should be equally applicable to naturally
synthesized RNAs as it is to in vitro transcribed RNAs, and
thus should allow the standardization of chemical probing
experimental protocols and data analysis.
The data presented in this work also represents a high-
quality benchmark SHAPE-Seq data set for a panel of
RNAs that are becoming the gold standard for technique
comparison in the field (19–21). As described in Supplemen-
tary Table S7, all data are freely available in the RNA Map-
ping Database (36). This should serve as a useful resource
for further experimental technique development, as well as
to researchers interested in using SHAPE-Seq data to con-
strain computational RNA folding algorithms to give more
accurate RNA structural models. In fact, as we have shown
above SHAPE-Seq ρ values can be used to make structural
predictions that are as accurate as those from more tradi-
tional SHAPE experiments (Table 1). It is our hope that this
data set serves as a starting point for understanding how
best to incorporate SHAPE-Seq data into computational
structure prediction.
Finally, we note that while this technique was originally
named ‘SHAPE-Seq’ after the SHAPE chemistry that was
used in the first version of the technique, it is in fact applica-
ble to any RNA structure-dependent chemical probe. With
our innovation of the SHAPE-Seq v2.0 universal priming
technique, and the already rigorous signal decay correc-
tion and accurate reactivity calculation offered by the Spats
pipeline (7,26–27), we anticipate SHAPE-Seq to be contin-
ued to be used in a wide array of powerful techniques aimed
at understanding the RNA sequence–structure relationship
at the heart of some of life’s most fundamental processes.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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